Walter Quan

530 total citations
37 papers, 409 citations indexed

About

Walter Quan is a scholar working on Oncology, Immunology and Cancer Research. According to data from OpenAlex, Walter Quan has authored 37 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 16 papers in Immunology and 8 papers in Cancer Research. Recurrent topics in Walter Quan's work include Cancer Immunotherapy and Biomarkers (16 papers), Immunotherapy and Immune Responses (14 papers) and CAR-T cell therapy research (11 papers). Walter Quan is often cited by papers focused on Cancer Immunotherapy and Biomarkers (16 papers), Immunotherapy and Immune Responses (14 papers) and CAR-T cell therapy research (11 papers). Walter Quan collaborates with scholars based in United States, Greece and Egypt. Walter Quan's co-authors include Grace E. Dean, Paul R. Walker, Vivek Khemka, Ekkehard Schütz, Howard B. Urnovitz, Glen J. Weiss, Donald P. Braun, Ashish Sangal, Betty Ferrell and Julia Beck and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Journal of Immunotherapy.

In The Last Decade

Walter Quan

36 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Walter Quan United States 10 248 162 100 85 60 37 409
Hyeong Chan Shin South Korea 9 145 0.6× 91 0.6× 106 1.1× 54 0.6× 90 1.5× 22 366
Yukinori Ozaki Japan 11 295 1.2× 49 0.3× 102 1.0× 66 0.8× 62 1.0× 51 385
Idoia Morilla Spain 10 359 1.4× 181 1.1× 129 1.3× 44 0.5× 42 0.7× 18 464
Lucía Teijeira Spain 10 400 1.6× 211 1.3× 100 1.0× 45 0.5× 48 0.8× 18 485
E Antoine France 7 294 1.2× 129 0.8× 160 1.6× 37 0.4× 112 1.9× 16 461
Ikuo Kamiyama Japan 10 187 0.8× 85 0.5× 193 1.9× 74 0.9× 81 1.4× 29 413
Yushen Wu China 14 213 0.9× 72 0.4× 114 1.1× 158 1.9× 215 3.6× 25 532
Robert S. Brody United States 6 269 1.1× 42 0.3× 176 1.8× 55 0.6× 50 0.8× 11 453
Gaetano Saggio Italy 13 210 0.8× 71 0.4× 70 0.7× 39 0.5× 94 1.6× 28 468
Ichiya Honma Japan 14 147 0.6× 166 1.0× 100 1.0× 54 0.6× 161 2.7× 28 576

Countries citing papers authored by Walter Quan

Since Specialization
Citations

This map shows the geographic impact of Walter Quan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter Quan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter Quan more than expected).

Fields of papers citing papers by Walter Quan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walter Quan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter Quan. The network helps show where Walter Quan may publish in the future.

Co-authorship network of co-authors of Walter Quan

This figure shows the co-authorship network connecting the top 25 collaborators of Walter Quan. A scholar is included among the top collaborators of Walter Quan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walter Quan. Walter Quan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gopinath, Arun, et al.. (2024). Interactive Pathology Tutorial in Neoplastic Hematology Disorders for Medical Hematology-Oncology Fellows. Journal of Cancer Education. 39(4). 413–417.
2.
Weiss, Glen J., Julia Beck, Donald P. Braun, et al.. (2017). Tumor Cell–Free DNA Copy Number Instability Predicts Therapeutic Response to Immunotherapy. Clinical Cancer Research. 23(17). 5074–5081. 113 indexed citations
3.
Turner, J. Francis, et al.. (2014). A Case of Pulmonary Infiltrates in a Patient with Colon Carcinoma. Case Reports in Oncology. 7(1). 39–42. 17 indexed citations
4.
Quan, Walter, et al.. (2013). Activity of Outpatient Intravenous Interleukin-2 and Famotidine in Metastatic Clear Cell Kidney Cancer. Cancer Biotherapy and Radiopharmaceuticals. 29(2). 58–61. 3 indexed citations
5.
Quan, Walter, et al.. (2010). Pulse Infusion Interleukin-2 with Famotidine and Cyclophosphamide Has Activity in Previously Treated Metastatic Melanoma. Cancer Biotherapy and Radiopharmaceuticals. 25(2). 179–183. 6 indexed citations
6.
Quan, Walter, et al.. (2009). High-Dose Intensity Pulse Interleukin-2 with Famotidine in Metastatic Kidney Cancer. Cancer Biotherapy and Radiopharmaceuticals. 24(2). 181–183. 5 indexed citations
7.
Quan, Walter, et al.. (2009). Activity of Continuous Infusion + Pulse Interleukin-2 with Famotidine in Metastatic Melanoma. Cancer Biotherapy and Radiopharmaceuticals. 24(1). 1–6. 5 indexed citations
8.
Quan, Walter, et al.. (2008). High-Dose Intensity Pulse Interleukin-2 with Famotidine Has Activity in Metastatic Melanoma. Cancer Biotherapy and Radiopharmaceuticals. 23(5). 641–646. 6 indexed citations
9.
Quan, Walter, et al.. (2008). Low-Dose Cyclophosphamide and Continuous-Infusion Interleukin-2 with Famotidine in Previously Treated Metastatic Melanoma or Kidney Cancer. Cancer Biotherapy and Radiopharmaceuticals. 23(1). 108–113. 7 indexed citations
10.
Quan, Walter, et al.. (2006). Activity of Continuous Infusion Plus Pulse Interleukin-2 with Famotidine in Patients with Metastatic Kidney Cancer or Melanoma Previously Treated with Interleukin-2. Cancer Biotherapy and Radiopharmaceuticals. 21(5). 437–442. 1 indexed citations
11.
Quan, Walter, et al.. (2006). Continuous Infusion Interleukin-2 and Famotidine in Metastatic Kidney Cancer. Cancer Biotherapy and Radiopharmaceuticals. 21(5). 515–519. 5 indexed citations
12.
Quan, Walter, et al.. (2006). Continuous Infusion Interleukin-2 and Intravenous Famotidine in Metastatic Melanoma. Cancer Biotherapy and Radiopharmaceuticals. 21(6). 607–612. 4 indexed citations
13.
14.
Walker, Paul R., Sadik Khuder, & Walter Quan. (2005). Continuous Infusion Interleukin-2 and Antihistamines in Metastatic Kidney Cancer. Cancer Biotherapy and Radiopharmaceuticals. 20(5). 487–490. 5 indexed citations
15.
Quan, Walter, et al.. (2005). Administration of High-Dose Continuous Infusion Interleukin-2 to Patients Age 70 or Over. Cancer Biotherapy and Radiopharmaceuticals. 20(1). 11–15. 14 indexed citations
16.
Quan, Walter, et al.. (2005). High-Dose Continuous Infusion Plus Pulse Interleukin-2 and Famotidine in Metastatic Kidney Cancer. Cancer Biotherapy and Radiopharmaceuticals. 20(1). 36–40. 6 indexed citations
17.
Quan, Walter, et al.. (2004). High-Dose Continuous Infusion Plus Pulse Interleukin-2 and Famotidine in Melanoma. Cancer Biotherapy and Radiopharmaceuticals. 19(6). 770–775. 10 indexed citations
18.
Khan, Nawazish A., et al.. (2004). Continuous Infusion Interleukin-2 and Antihistamines in Melanoma: A Retrospective Review Showing Activity of This Combination. Cancer Biotherapy and Radiopharmaceuticals. 19(6). 754–757. 3 indexed citations
19.
Quan, Walter, et al.. (2004). Repeated Cycles with 72-Hour Continuous Infusion Interleukin-2 in Kidney Cancer and Melanoma. Cancer Biotherapy and Radiopharmaceuticals. 19(3). 350–354. 14 indexed citations
20.
Quan, Walter, et al.. (2003). Outpatient Experience With Moderate Dose Bolus Interleukin-2 in Metastatic Malignant Melanoma and Kidney Cancer. Journal of Immunotherapy. 26(3). 286–290. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hyeong Chan Shin Breakdown of academic impact, for papers by Yukinori Ozaki Breakdown of academic impact, for papers by Idoia Morilla Breakdown of academic impact, for papers by Lucía Teijeira Breakdown of academic impact, for papers by E Antoine Breakdown of academic impact, for papers by Ikuo Kamiyama Breakdown of academic impact, for papers by Yushen Wu Breakdown of academic impact, for papers by Robert S. Brody Breakdown of academic impact, for papers by Gaetano Saggio Breakdown of academic impact, for papers by Ichiya Honma
Rankless by CCL
2026